GeoWealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$764K Buy
4,017
+771
+24% +$133K 0.02% 389
2026
Q1
$548K Buy
3,246
+1,748
+117% +$299K 0.02% 457
2025
Q4
$253K Buy
+1,498
New +$243K 0.01% 615
2024
Q4
Sell
-1
Closed -$146 1842
2024
Q3
$146 Buy
+1
New +$145 ﹤0.01% 1665

Other funds holding IBB

GeoWealth Management's IBB Position: Q2 2026 in Review

GeoWealth Management increased its iShares Biotechnology ETF (IBB) stake by 24% in Q2 2026, buying an estimated $133K and bringing the position to 4,017 shares worth $764K. The position accounts for 0.02% of the portfolio, ranked #389.

GeoWealth Management first reported a position in IBB in Q3 2024 and has held it in 4 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • GeoWealth Management held 4,017 shares of iShares Biotechnology ETF worth $764K as of Q2 2026.
  • GeoWealth Management bought 771 iShares Biotechnology ETF shares in Q2 2026, an estimated $133K.
  • iShares Biotechnology ETF made up 0.02% of GeoWealth Management's portfolio in Q2 2026, its #389 holding.
  • GeoWealth Management first reported a position in iShares Biotechnology ETF in Q3 2024 and has held it in 4 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on GeoWealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.